Generic placeholder image

Current Pharmaceutical Design


ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Evolving Concepts Concerning Cardiac β-Adrenoceptor Function in Heart Failure

Author(s): J. Black and D. Fitzgerald

Volume 16, Issue 37, 2010

Page: [4148 - 4158] Pages: 11

DOI: 10.2174/138161210794519200

Price: $65


This review describes the clinical application of β-adrenergic blocking drugs over time in patients with congestive heart failure. The different pharmacological properties of these drugs in relation to clinical outcomes raise questions as to their optimal desirable profile based on studies showing the undesirable effects of excessive β2-AR activation. The rationale for the use of selective β2-AR antagonists in heart failure is discussed.

Keywords: Selective adrenoceptor blockade, heart failure, MAP/ERK activation

« Previous

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy